UCB UCB SA

EBR · BE · Healthcare · Biotechnology · ucb.com
307.34USD279.60 EUR · EBR-1.27%Mkt Cap: 58.60B USDP/E: 24.70

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company offers Cimzia for ankylosing spondylitis (AS), axial spondyloarthritis, Crohn'…